From: Identification and characterization of a novel nasopharyngeal carcinoma-associated peptide: NAP-1
case number | N(IA) | T(IA) | T(IA) / N(IA) | case number | N(IA) | T(IA) | T(IA) / N(IA) |
---|---|---|---|---|---|---|---|
1 | 2.77 | 0.06 | 0.02 | 2 | 0.68 | 0.00 | 0.00 |
3 | 3.33 | 0.40 | 0.12 | 4 | 0.13 | 0.08 | 0.61 |
5 | 4.03 | 2.30 | 0.57 | 6 | 2.86 | 0.00 | 0.00 |
7 | 0.47 | 0.00 | 0.00 | 8 | 0.01 | 0.98 | 98.00 |
9 | 1.43 | 1.72 | 1.20 | 10 | 0.88 | 1.84 | 2.09 |
11 | 0.81 | 0.56 | 0.70 | 12 | 0.89 | 0.30 | 0.34 |
13 | 0.93 | 0.98 | 1.03 | 14 | 0.01 | 0.70 | 70.00 |
15 | 1.06 | 0.16 | 0.15 | 16 | 0.71 | 0.46 | 0.65 |
17 | 0.08 | 0.26 | 3.25 | 18 | 2.48 | 0.01 | 0.00 |
19 | 0.16 | 0.30 | 1.88 | 20 | 1.60 | 0.48 | 0.30 |
21 | 1.16 | 0.46 | 0.40 | 22 | 0.53 | 0.61 | 1.15 |
23 | 0.50 | 0.32 | 0.64 | 24 | 1.88 | 0.68 | 0.36 |
25 | 0.83 | 0.82 | 0.99 | 26 | 0.60 | 0.00 | 0.00 |
27 | 5.34 | 5.50 | 1.03 | 28 | 8.01 | 0.45 | 0.06 |
29 | 0.86 | 0.73 | 0.85 | 30 | 1.03 | 3.09 | 3.00 |
31 | 1.07 | 0.97 | 0.91 | 32 | 0.81 | 1.20 | 1.48 |
33 | 1.36 | 0.18 | 0.13 | 34 | 0.12 | 0.27 | 2.25 |
35 | 0.25 | 0.00 | 0.00 | 36 | 0.06 | 0.00 | 0.00 |
37 | 0.27 | 0.17 | 0.63 | 38 | 0.01 | 0.00 | 0.00 |
39 | 0.68 | 0.47 | 0.69 | 40 | 0.44 | 0.75 | 1.70 |